厄贝沙坦联合针灸治疗原发性高血压的临床研究

Clinical study of irbesartan combined with acupuncture and moxibustion in the treatment of essential hypertension

目的:探究厄贝沙坦联合针灸治疗原发性高血压的临床疗效。方法:选取原发性高血压患者60例,随机分为对照组和研究组,每组30例,对照组患者给予厄贝沙坦进行治疗,研究组患者在对照组患者治疗的基础上加以针灸治疗,连续治疗4周。比较两组患者临床疗效及不良反应发生情况。结果:治疗后两组患者血压均有所改善,对照组患者治疗总有效率为66.7%,研究组患者治疗总有效率为93.3%,差异具有统计学意义(P<0.05);对照组患者不良反应发生率10%,研究组患者不良反应发生率为6.67%,差异无统计学意义(P>0.05)。结论:厄贝沙坦联合针灸治疗原发性高血压临床疗效显著,不良反应发生率低,是一种安全、有效的治疗方法,建议临床上推广应用。

Objective To investigate the clinical efficacy of irbesartan combined with acupuncture and moxibustion in the treatment of essential hypertension. Method 60 patients with primary hypertension were chosen and randomly divided into control group and study group. 30 patients in each group were treated with irbesartan. Patients of control group were treated with irbesartan,patients of research group were treated with acupuncture treatment on the base of control group,continuous treatment for 4 weeks. The clinical efficacy and adverse events were compared between these two groups. Results The total effective rate was66. 7% in the control group and 93. 3% in the study group,the difference was statistically significant（ P〈 0. 05）; the adverse reaction rate of control group was 10%,of study group was 6. 67%,the difference was not statistically significant（ P〉 0. 05）. Conclusion Irbesartan combined with acupuncture and moxibustion treatment of primary hypertension clinical efficacy is significant,the incidence of adverse reactions is low,is a safe and effective treatment,the proposed clinical application.